Bruderman Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Bruderman Asset Management's NVS Position: Q4 2019 in Review
Bruderman Asset Management sold out of Novartis (NVS) in Q4 2019, closing a stake of 3,192 shares — an estimated $282K sold.
Bruderman Asset Management first reported a position in NVS in Q1 2015 and held it in 19 quarters. The position peaked at $7.34M in Q2 2016. 1,172 funds tracked by Wall St. Rank hold NVS as of Q4 2019.
- Bruderman Asset Management reported no remaining Novartis position as of Q4 2019 after selling out during the quarter.
- Bruderman Asset Management sold 3,192 Novartis shares in Q4 2019, an estimated $282K.
- Bruderman Asset Management first reported a position in Novartis in Q1 2015 and held it in 19 quarters.
- Bruderman Asset Management's Novartis position peaked at $7.34M in Q2 2016.
- 1,172 funds tracked by Wall St. Rank held Novartis as of Q4 2019.
Based on Bruderman Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.